ERK-1 MAP kinase prevents TNF-induced apoptosis through bad phosphorylation and inhibition of bax translocation in HeLa cells

Journal of Cellular Biochemistry

Volumn 108, Issue 5, 2009, Pages 1166-1174

  Pucci, Bruna ^a   Indelicato, Manuela ^a   Paradisi, Valentina ^b   Reali, Valentina ^b   Pellegrini, Laura ^b   Aventaggiato, Michele ^b   Karpinich, Natalie O ^c   Fini, Massimo ^a   Russo, Matteo A ^a,b   Farber, John L ^d   Tafani, Marco ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Anisomycin; Bad phosphorylation; Bax; Erk 1; TNF

Indexed keywords

ANISOMYCIN; BONGKREKIC ACID; CASPASE 8; CYCLOHEXIMIDE; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BAX; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 8; CYCLOHEXIMIDE; GENE TARGETING; HELA CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 72449171663     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22345     Document Type: Article

References (41)

1. Balmanno K, Cook SJ. 2009. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16:368-377.
2. Basu A, You SA, Haldar S. 2000. Regulation of Bcl2 phosphorylation by stress response kinase pathway. Int J Oncol 16:497-500.
3. Breckenridge DG, Xue D. 2004. Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 16:647-652. (Pubitemid 39463115)
4. Buchwalter G, Gross C, Wasylyk B. 2004. Ets ternary complex transcription factors. Gene 324:1-14. (Pubitemid 38030321)
5. Chen L, He HY, Li HM, Zheng J, Heng WJ, You JF, Fang WG. 2004. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett 215:239-247. (Pubitemid 39370042)
6. Chen J, Volpi S, Aguilera G. 2008. Anti-apoptotic actions of vasopressin in H32 neurons involve MAP kinase transactivation and Bad phosphorylation. Exp Neurol 211:529-538.
7. Cohen M, Meisser A, Haenggeli L, Bischof P. 2006. Involvement of MAPK pathway in TNF-a-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod 12:225-232. (Pubitemid 43779073)
8. Deng X, Xiao L, Lang W, Gao F, Ruvolo P, May WS, Jr. 2001. Novel role for JNK as a stress-activated Bcl2 kinase. J Biol Chem 276:23681-23688.
9. Dhanasekaran DN, Reddy EP. 2008. JNK signaling in apoptosis. Oncogene 27:6245-6251.
10. Frost JA, Geppert TD, Cobb MH, Feramisco JR. 1994. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci USA 91:3844-3848.
11. Gross A, McDonnell JM, Korsmeyer SJ. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911. (Pubitemid 29407357)
12. Handra-Luca A, Bilal H, Bertrand JC, Fouret P. 2003. Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: Association to aggressive tumor behavior and tumor cell proliferation. Am J Pathol 163:957-967. (Pubitemid 37040131)
13. Johnson GL, Nakamura K. 2007. The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease. Biochim Biophys Acta 1773:1341-1348. (Pubitemid 47125977)
14. Kim J, Lee CK, Park HJ, Kim HJ, So HH, Lee KS, Lee HM, Roh HY, Choi WS, Park TK, Kim B. 2006. Epidermal growth factor induces vasoconstriction through the phosphatidylinositol 3-kinase-mediated mitogen-activated protein kinase pathway in hypertensive rats. J Pharmacol Sci 101:135-143. (Pubitemid 43938764)
15. Kondoh K, Nishida E. 2007. Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 1773:1227-1237. (Pubitemid 47125976)
16. Kondoh K, Torii S, Nishida E. 2005. Control of MAP kinase signaling to the nucleus. Chromosoma 114:86-91. (Pubitemid 41030971)
17. Li Q, Yang Z. 2009. Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations. J Exp Clin Cancer Res 28:65.
18. Li H, Zhu H, Xu CJ, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501. (Pubitemid 28391865)
19. Lu Z, Xu S. 2006. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58:621-631. (Pubitemid 44691463)
20. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490. (Pubitemid 28391864)
21. Orrenius S. 2004. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149:19-23. (Pubitemid 38469816)
22. + depletion prevents anoxic death of hepatocytes by inhibiting mitochondrial permeability transition. Am J Physiol 268:C676-C685.
23. Pastorino JG, Tafani M, Farber JL. 1999. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J Biol Chem 274:19411-19416. (Pubitemid 129519374)
24. Petros AM, Olejniczak ET, Fesik SW. 2004. Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644:83-94. (Pubitemid 38281265)
25. Raman M, Chen W, Cobb MH. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
26. Ramos JW. 2008. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40:2707-2719.
27. Rouleau C, Matécki S, Kalfa N, Costes V, de Santa Barbara P. 2009. Activation of MAP kinase (ERK1/2) in human neonatal colonic enteric nervous system. Neurogastroenterol Motil 21:207-214.
28. Sastry KS, Karpova Y, Kulik G. 2006. Epidermal growth factor protects prostate cancer cells from apoptosis by inducing BAD phosphorylation via redundant signaling pathways. J Biol Chem 281:27367-27377. (Pubitemid 44401764)
29. Scheid MP, Schubert KM, Duronio V. 1999. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 274:31108-31113. (Pubitemid 129576867)
30. Sharpe JC, Arnoult D, Youle RJ. 2004. Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta 1644:107-113. (Pubitemid 38281267)
31. Shaul YD, Seger R. 2007. The MEK/ERK cascade: From signaling specificity to diverse functions. Biochim Biophys Acta 1773:1213-1226. (Pubitemid 47125968)
32. Shi J, Shen HM. 2008. Critical role of Bid and Bax in indirubin-3′-monoxime-induced apoptosis in human cancer cells. Biochem Pharmacol 75:1729-1742.
33. Strasser A, O'Connor L, Dixit VM. 2000. Apoptosis signaling. Annu Rev Biochem 69:217-245.
34. Tafani M, Minchenko DA, Serroni A, Farber JL. 2001. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res 61:2459-2466. (Pubitemid 32685824)
35. Tzivion G, Shen YH, Zhu J. 2001. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20:6331-6338. (Pubitemid 32977842)
36. Weston CR, Davis RJ. 2007. The JNK signal transduction pathway. Curr Opin Cell Biol 19:142-149.
37. Wu J, Wong WW, Khosravi F, Minden MD, Penn LZ. 2004. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer Res 64:6461-6468. (Pubitemid 39297901)
38. Yang R, Trevillyan JM. 2008. c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol 40:2702-2706.
39. Youle RJ, Strasser A. 2008. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47-59.
40. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628. (Pubitemid 26386936)
41. Zhang X, Li B, Song M, Song Y. 2004. Expression and significance of ERK protein in human breast carcinoma. Chin J Cancer Res 16:269-273. (Pubitemid 40127743)